Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Recs

0
Player Avatar svande8952 (< 20) Submitted: 6/16/2009 11:09:34 AM : Underperform Start Price: $12.24 AGEN Score: +102.50

recent run up looks prime for thumbs down

Report this Post Reply

Featured Broker Partners


Advertisement